The National Institutes of Health (NIH) on September 30 announced 52 highly competitive awards for high-risk, high-payoff research for young biomedical scientists, and UCSF tops California institutions with four recipients.
September 29, 2010
A particularly aggressive childhood cancer can be fought successfully with far less chemotherapy than previously believed, avoiding harmful side effects caused by cancer drugs.
September 24, 2010
Renown Institute for Cancer in Reno and the UCSF Helen Diller Family Comprehensive Cancer Center, the two leading cancer programs in their regions, have joined forces to enhance patient care and improve access to top level medical experts.
September 24, 2010
Genentech scientist Napoleone Ferrara, who has just been named the winner of a Lasker Award, is being recognized for his noteworthy achievements made when he was a postdoc at UCSF.
September 21, 2010
Cancer and infertility can be a double blow. Many women become infertile following cancer treatment. And because more women are living longer thanks to modern chemotherapy and radiation treatment, more are later discovering that they cannot bear children.
September 10, 2010
Nobel laureate Elizabeth Blackburn, president of the American Association for Cancer Research, will deliver a prime time pitch for Stand Up To Cancer to raise funds for groundbreaking translational research that can get new therapies to patients quickly and save lives.
August 16, 2010
A UCSF-led team has discovered at least one key reason why blood stem cells are susceptible to developing the genetic mutations that can lead to adult leukemia.
August 09, 2010
A UCSF-led team has discovered a direct link between an inherited genetic mutation, a set of developmental abnormalities and a rare form of childhood leukemia called juvenile myelomonocytic leukemia, or JMML.
August 05, 2010
Surgery for localized prostate cancer offers a significantly higher survival rate than either external-beam radiation or hormonal therapies, according to a new study led by researchers at UCSF.
July 02, 2010
Antibiotic-resistant Staph infection is not the only emerging bacterial threat. Now a different bug -- Clostridium difficile -- is gaining strength.